STARTUP PROFILE

Reach Neuro

COUNTRY
USA
FOUNDED
2021
CATEGORY
Neuromodulation
Developing implantable spinal cord stimulation systems (Avantis) that restore voluntary upper-limb movement in chronic stroke survivors.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
SCS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Stroke
TARGET USER
Patients
REGULATORY STAGE
Investigational
Reach Neuro is developing implantable spinal cord stimulation systems specifically for upper-limb recovery after stroke, placing it in the restorative neurorehabilitation category. Its indication focus is distinctive, though proving durable motor benefit will be essential.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Reach Neuro
No items found.